A Randomized, Double-blind Phase III Clinical Study of ZSP1273 Tablets Compared With Placebo or Oseltamivir Patients With Acute Uncomplicated Influenza A
Latest Information Update: 29 Jun 2023
At a glance
- Drugs Onradivir (Primary) ; Oseltamivir
- Indications Influenza A virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Guangdong Raynovent Biotech
- 24 Jun 2023 Status changed from active, no longer recruiting to completed.
- 14 Jun 2023 Planned End Date changed from 1 Jun 2022 to 1 Sep 2023.
- 14 Jun 2023 Status changed from not yet recruiting to active, no longer recruiting.